Cancer (Oncology)

Votrient 200® Pazopanib Tablets
Pazopanib 200mg
- Composition
- Pazopanib 200mg
- Dosage form
- Tablet
- Pack size
- Bottle of 30 Tablet
- Manufacturer
- Gsk
- Also known as
- Votrient
Supplied against a valid prescription where required, in line with the regulations of the destination country.
Votrient 200 mg contains pazopanib, a targeted anticancer medicine used to treat advanced renal cell carcinoma (kidney cancer) and certain advanced soft-tissue sarcomas following prior chemotherapy
As prescribed by a doctor. Dose and duration depend on the condition being treated and the patient. Do not change the dose without medical advice.
Side effects vary by patient. Common and serious side effects are listed in the pack insert. Contact a doctor if you have severe or unexpected symptoms.
Tell your doctor about other medicines you take, allergies, pregnancy or breastfeeding, and any liver or kidney conditions before use.
Store below 30 °C in a dry place, in the original pack, out of reach of children.
Need product documents?
Ask for the pack insert, batch details or a COA with your quote.
Ask on WhatsApp →Related products
Cancer (Oncology)
Cancer (Oncology)
Cancer (Oncology)
Cancer (Oncology)
